News
A new big data-based predictive model developed in Hong Kong enables more dynamic monitoring of six common cardiovascular diseases by capturing near-real-time biological changes.
The hybrid doula-focused care platform will use the seed funding to scale nationwide.
The Series B marks the company's third funding round in less than a year.
The new alliance adds to b.well's partnerships with OpenAI, Google and Samsung to unify and personalize AI-driven health answers using individuals' medical data.
The company will use the funds to enhance its platform, grow its workforce and expand partnerships with health systems to automate medication approval workflows.
The company will use the funds to accelerate development of its AI precision health platform.
The company acquired Intelerad for $2.3 billion in cash and debt financing and expects around $270 million in recurring annual revenue and a high-single-digit return on investment within five years.
The company will use the funds to scale its platform, hire engineers and data scientists, deepen clinical integrations and speed the deployment of custom AI agents.
The new Microsoft Copilot Health, which will be available through a phased rollout, is aimed at helping people better understand their health records and wearable data through AI analysis.
The company's lab allows AI systems to create, evaluate and deploy new machine learning models with minimal human intervention.